Abstract
Use of an anti-IL-20 antibody, either alone or in combination with an anti-RANKL antibody, for treating breast cancer and inhibiting cancer-associated bone loss.
| Original language | English |
|---|---|
| Patent number | 特許第5167408號 |
| Publication status | Published - 1800 |
Fingerprint
Bone Neoplasms
Anti-Idiotypic Antibodies
Breast Neoplasms
Antibodies
interleukin 20
Cite this
Chang, M-S. (1800). Anti-IL-20 antibody and its use in treating IL-20 associated inflammatory diseases. (Patent No. 特許第5167408號).
@misc{c6820d40b4664506abf1e6ef25546e13,
title = "Anti-IL-20 antibody and its use in treating IL-20 associated inflammatory diseases",
abstract = "Use of an anti-IL-20 antibody, either alone or in combination with an anti-RANKL antibody, for treating breast cancer and inhibiting cancer-associated bone loss.",
author = "Ming-Shi Chang",
year = "1800",
language = "English",
type = "Patent",
note = "特許第5167408號",
}
Chang, M-S 1800, Anti-IL-20 antibody and its use in treating IL-20 associated inflammatory diseases, Patent No. 特許第5167408號.
Anti-IL-20 antibody and its use in treating IL-20 associated inflammatory diseases. / Chang, Ming-Shi (Inventor).
Patent No.: 特許第5167408號.Research output: Patent
TY - PAT
T1 - Anti-IL-20 antibody and its use in treating IL-20 associated inflammatory diseases
AU - Chang, Ming-Shi
PY - 1800
Y1 - 1800
N2 - Use of an anti-IL-20 antibody, either alone or in combination with an anti-RANKL antibody, for treating breast cancer and inhibiting cancer-associated bone loss.
AB - Use of an anti-IL-20 antibody, either alone or in combination with an anti-RANKL antibody, for treating breast cancer and inhibiting cancer-associated bone loss.
M3 - Patent
M1 - 特許第5167408號
ER -
Chang M-S, inventor. Anti-IL-20 antibody and its use in treating IL-20 associated inflammatory diseases. 特許第5167408號. 1800.